triheptanoin has been researched along with carnitine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Essén-Gustavsson, B; McCue, ME; Pagan, JD; Roe, CR; Valberg, SJ | 1 |
| Brunengraber, H; Roe, CR | 1 |
| Comhair, TM; Dejong, CH; Garcia Caraballo, SC; Koehler, SE; Lamers, WH | 1 |
| Burchill, LJ; DeLany, JP; Deward, S; El-Gharbawy, AH; Gillingham, MB; Goldstein, A; Goodpaster, B; Harding, CO; Heitner, SB; Lasarev, MR; Martin, J; Matern, D; Pollaro, J; Rose, S; Shoemaker, J; Vockley, J | 1 |
| Chang, IJ; Gunnarson, M; Hahn, S; Lam, C; McKean, KN; Merritt, JL; Norris, MK; Scott, AI; Sullivan, S; Sun, A; Thies, JM | 1 |
| De Lonlay, P; Douillard, C; Guffon, N; Mochel, F; Schiff, M; Vianey-Saban, C | 1 |
2 trial(s) available for triheptanoin and carnitine
| Article | Year |
|---|---|
Effect of triheptanoin on muscle metabolism during submaximal exercise in horses.
Topics: Analysis of Variance; Animals; Blood Glucose; Carbohydrate Metabolism; Carnitine; Corn Oil; Cross-Over Studies; Horses; Insulin; Lipid Metabolism; Muscle, Skeletal; Physical Conditioning, Animal; Random Allocation; Triglycerides | 2009 |
Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adolescent; Adult; Caprylates; Cardiomyopathies; Carnitine; Child; Dietary Fats; Double-Blind Method; Exercise; Fatty Acids; Female; Humans; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Mitochondrial Myopathies; Mitochondrial Trifunctional Protein; Nervous System Diseases; Oxidation-Reduction; Rhabdomyolysis; Triglycerides; Young Adult | 2017 |
4 other study(ies) available for triheptanoin and carnitine
| Article | Year |
|---|---|
Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience.
Topics: Administration, Oral; Adolescent; Adult; Carnitine; Child; Child, Preschool; Citric Acid; Fatty Acids; Female; Humans; Infant; Infant, Newborn; Lactic Acid; Lipid Metabolism, Inborn Errors; Malates; Male; Middle Aged; Mitochondrial Diseases; Oxidation-Reduction; Succinic Acid; Survival Analysis; Treatment Outcome; Triglycerides | 2015 |
The odd-carbon medium-chain fatty triglyceride triheptanoin does not reduce hepatic steatosis.
Topics: Acyl-CoA Oxidase; Animals; Blood Glucose; Carnitine; CD36 Antigens; Cholesterol; Diet, High-Fat; Diet, High-Protein; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Fatty Liver; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; Phosphoenolpyruvate Carboxykinase (GTP); PPAR alpha; Triglycerides; Uncoupling Protein 2 | 2017 |
Tutorial: Triheptanoin and Nutrition Management for Treatment of Long-Chain Fatty Acid Oxidation Disorders.
Topics: Carnitine; Fatty Acids; Humans; Lipid Metabolism, Inborn Errors; Oxidation-Reduction; Triglycerides | 2021 |
Clinical outcomes in a series of 18 patients with long chain fatty acids oxidation disorders treated with triheptanoin for a median duration of 22 months.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adolescent; Adult; Carnitine; Child; Child, Preschool; Female; Humans; Infant; Male; Metabolic Diseases; Oxidation-Reduction; Quality of Life; Retrospective Studies; Treatment Outcome; Triglycerides; Young Adult | 2021 |